Nonsteroidal antiinflammatory drug hydroxamic acids. Dual inhibitors of both cyclooxygenase and 5-lipoxygenase.
作者信息
Flynn D L, Capiris T, Cetenko W J, Connor D T, Dyer R D, Kostlan C R, Nies D E, Schrier D J, Sircar J C
机构信息
Department of Chemistry, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
出版信息
J Med Chem. 1990 Aug;33(8):2070-2. doi: 10.1021/jm00170a004.
PMID:2115586
Abstract
摘要
相似文献
1
Nonsteroidal antiinflammatory drug hydroxamic acids. Dual inhibitors of both cyclooxygenase and 5-lipoxygenase.
J Med Chem. 1990 Aug;33(8):2070-2. doi: 10.1021/jm00170a004.
2
Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.二苯并氧杂庚英酮羟胺和异羟肟酸：环氧合酶和5-脂氧合酶的双重抑制剂，具有强效局部抗炎活性。
J Med Chem. 1996 Jan 5;39(1):246-52. doi: 10.1021/jm950563z.
3
Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro.甲氯芬那酸钠在体外是花生四烯酸级联反应中5-脂氧合酶和环氧化酶途径的抑制剂。
Prostaglandins Leukot Med. 1986 Aug;23(2-3):229-38. doi: 10.1016/0262-1746(86)90190-3.
4
The in vivo antiinflammatory effects of (E)-2,6-bis(1,1-dimethyl-ethyl)-4-[2-(5-methyl-1H-pyrazol-3-yl)ethenyl ] phenol (PD 127443) a novel dual inhibitor of 5-lipoxygenase and cyclooxygenase.（E）-2,6-双（1,1-二甲基乙基）-4-[2-（5-甲基-1H-吡唑-3-基）乙烯基]苯酚（PD 127443）的体内抗炎作用，5-脂氧合酶和环氧化酶的新型双重抑制剂。
Agents Actions. 1989 Jun;27(3-4):391-4. doi: 10.1007/BF01972831.
5
Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.非甾体抗炎药（NSAIDs）的乙磺羟肟酸酯前药：合成、一氧化氮和亚硝自由基释放、环氧化酶抑制、抗炎和溃疡指数研究。
J Med Chem. 2011 Mar 10;54(5):1356-64. doi: 10.1021/jm101403g. Epub 2011 Jan 31.
6
Acetohydroxamic acids as potent, selective, orally active 5-lipoxygenase inhibitors.乙酰氧肟酸作为强效、选择性、口服活性的5-脂氧合酶抑制剂。
J Med Chem. 1988 Mar;31(3):499-500. doi: 10.1021/jm00398a001.
7
Hydroxamic acid inhibitors of 5-lipoxygenase.5-脂氧合酶的异羟肟酸抑制剂
J Med Chem. 1987 Mar;30(3):574-80. doi: 10.1021/jm00386a022.
8
The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.
Agents Actions. 1987 Aug;21(3-4):316-9. doi: 10.1007/BF01966502.
9
Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition.FMLP诱导豚鼠肺泡巨噬细胞释放血小板活化因子乙酰醚和类花生酸：环氧化酶和脂氧合酶抑制的作用
Eur J Pharmacol. 1989 May 30;164(3):539-46. doi: 10.1016/0014-2999(89)90262-8.
10
FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.FPL 62064，一种局部活性的5-脂氧合酶/环氧化酶抑制剂。
Agents Actions. 1990 Jun;30(3-4):432-42. doi: 10.1007/BF01966309.
引用本文的文献
1
In Vitro Evaluation of Pharmacokinetic Properties of Selected Dual COX-2 and 5-LOX Inhibitors.选定的环氧化酶-2（COX-2）和5-脂氧合酶（5-LOX）双重抑制剂药代动力学特性的体外评价
Pharmaceuticals (Basel). 2024 Oct 5;17(10):1329. doi: 10.3390/ph17101329.
2
The novel amidocarbamate derivatives of ketoprofen: synthesis and biological activity.酮洛芬的新型氨基甲酸酯衍生物：合成与生物活性
Med Chem Res. 2011;20(2):210-219. doi: 10.1007/s00044-010-9309-2. Epub 2010 Feb 3.
Zotero 插件